LACK OF CONCOMITANT DRUG EFFECT

LACK OF CONCOMITANT DRUG EFFECT was reported 57 times

LACK OF CONCOMITANT DRUG EFFECT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Pyruvate Kinase Activator [EPC] 1 0.0008
1 Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] 1 0.0003
2 Orexin Receptor Antagonist [EPC] 3 0.0002
3 beta3-Adrenergic Agonist [EPC] 5 0.0001
4 Aminosalicylate [EPC] 8 0.0001
5 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
6 Androgen [EPC] 2 0.0001
7 Nonergot Dopamine Agonist [EPC] 1 0.0001
8 Serotonin-3 Receptor Antagonist [EPC] 8 0.0001
9 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1 0.0000
10 alpha-Adrenergic Blocker [EPC] 5 0.0000
11 GLP-1 Receptor Agonist [EPC] 15 0.0000
12 Opioid Agonist [EPC] 8 0.0000
13 Anti-epileptic Agent [EPC] 6 0.0000
14 Phosphodiesterase 5 Inhibitor [EPC] 3 0.0000
15 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
16 Fluoroquinolone Antibacterial [EPC] 2 0.0000
17 Benzodiazepine [EPC] 10 0.0000
18 Janus Kinase Inhibitor [EPC] 2 0.0000
19 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
20 Corticosteroid [EPC] 14 0.0000
21 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
22 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
23 Acetylcholine Release Inhibitor [EPC] 1 0.0000
24 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
25 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
26 Kinase Inhibitor [EPC] 3 0.0000
27 Expectorant [EPC] 1 0.0000
28 Thiazide Diuretic [EPC] 1 0.0000
29 Mood Stabilizer [EPC] 1 0.0000
30 Alkylating Drug [EPC] 1 0.0000
31 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
32 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
33 Insulin Analog [EPC] 1 0.0000
34 Proton Pump Inhibitor [EPC] 1 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000